Scilex Holding Co financial data

Symbol
SCLX, SCLXW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
960 San Antonio Road, Palo Alto, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Scilex Holding Company/DE (to 11/30/2022), Vickers Vantage Corp. I (to 11/15/2022)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 21.5 % -61.3%
Quick Ratio 1.77 %
Debt-to-equity -178 % -123%
Return On Equity 83.9 % +102%
Return On Assets -108 % -150%
Operating Margin -211 % -31.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 166 M shares +14%
Common Stock, Shares, Outstanding 106 M shares -27.2%
Entity Public Float 480 M USD +382%
Common Stock, Value, Issued 17 K USD +13.3%
Weighted Average Number of Shares Outstanding, Basic 130 M shares -2.93%
Weighted Average Number of Shares Outstanding, Diluted 130 M shares -2.93%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 47 M USD +12.5%
Cost of Revenue 15.9 M USD +20.3%
Research and Development Expense 13.1 M USD +43.2%
Operating Income (Loss) -99.4 M USD -47.7%
Nonoperating Income (Expense) -8.89 M USD -133%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -108 M USD -140%
Income Tax Expense (Benefit) 5 K USD -44.4%
Net Income (Loss) Attributable to Parent -108 M USD -140%
Earnings Per Share, Basic -1.3 USD/shares -306%
Earnings Per Share, Diluted -1.3 USD/shares -306%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.82 M USD -64.1%
Accounts Receivable, after Allowance for Credit Loss, Current 29.7 M USD +54.4%
Inventory, Net 3.49 M USD +53.2%
Assets, Current 37.7 M USD +21.4%
Property, Plant and Equipment, Net 718 K USD -5.77%
Operating Lease, Right-of-Use Asset 2.76 M USD +180%
Intangible Assets, Net (Excluding Goodwill) 35.5 M USD -10.4%
Goodwill 13.5 M USD 0%
Assets 91.2 M USD +6.03%
Accounts Payable, Current 42.2 M USD +330%
Liabilities, Current 253 M USD +291%
Operating Lease, Liability, Noncurrent 2.07 M USD +349%
Other Liabilities, Noncurrent 182 K USD +8.33%
Liabilities 281 M USD +275%
Retained Earnings (Accumulated Deficit) -515 M USD -26.5%
Stockholders' Equity Attributable to Parent -190 M USD -1813%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -190 M USD -1813%
Liabilities and Equity 91.2 M USD +6.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 9.39 M USD
Net Cash Provided by (Used in) Financing Activities -11.2 M USD -205%
Net Cash Provided by (Used in) Investing Activities -150 K USD
Common Stock, Shares Authorized 740 M shares 0%
Common Stock, Shares, Issued 166 M shares +14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.96 M USD -168%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.77 M USD -45.3%
Deferred Tax Assets, Valuation Allowance 96.8 M USD +43.3%
Deferred Tax Assets, Gross 100 M USD +42.3%
Operating Lease, Liability 2.8 M USD +127%
Depreciation 34 K USD -15%
Lessee, Operating Lease, Liability, to be Paid 3.01 M USD +121%
Property, Plant and Equipment, Gross 753 K USD -19.8%
Operating Lease, Liability, Current 731 K USD -5.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 944 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 916 K USD +30.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure -8.48%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 211 K USD +68.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 724 K USD
Deferred Tax Assets, Operating Loss Carryforwards 71.4 M USD +45.8%
Preferred Stock, Shares Issued 29.1 M shares 0%
Preferred Stock, Shares Authorized 45 M shares 0%
Unrecognized Tax Benefits 1.07 M USD +163%
Lessee, Operating Lease, Liability, to be Paid, Year Four 724 K USD
Operating Lease, Payments 277 K USD +28.2%
Additional Paid in Capital 415 M USD -0.57%
Preferred Stock, Shares Outstanding 29.1 M shares 0%
Amortization of Intangible Assets 4.11 M USD +2.29%
Depreciation, Depletion and Amortization 1.03 M USD -0.58%
Deferred Tax Assets, Net of Valuation Allowance 3.49 M USD +19.7%
Share-based Payment Arrangement, Expense 14.4 M USD +88.8%
Interest Expense 531 K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%